Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology|June 15, 2017
The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgeryChristoph Grimm, Philipp Harter, Pier F Alesina, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2023
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centresRichard Schwameis, Francesco Fanfani, Christoph Ebner, et al.
Gynecologic Oncology|February 18, 2022
Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trialStephan Polterauer, Olaf Reich, Andreas Widschwendter, et al.
BMC Cancer|September 19, 2013
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortiumAnna Bachmayr-Heyda, Stefanie Aust, Georg Heinze, et al.
International Journal of Surgery (London, England)|April 19, 2020
Low anterior resection syndrome (LARS) in ovarian cancer patients - A multi-centre comparative cohort studyFelix Harpain, Marlene Kranawetter, Tobias Zott, et al.
Oncotarget|March 9, 2019
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncologyGerald W Prager, Matthias Unseld, Fredrik Waneck, et al.
Gynecologic Oncology|February 15, 2019
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 studyStephan Polterauer, Richard Schwameis, Christoph Grimm, et al.
Oncogene|July 4, 2023
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortiumNicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2024
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancerAlejandro Perez-Fidalgo, Barbara Schmalfeldt, Angela George, et al.
Cancer Letters|June 1, 2019
Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancerCaroline Kreuzinger, Isabel von der Decken, Andrea Wolf, et al.
Pageof 17